Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac vs Paracetamol as Adjunct to Nalbuphine in Cardiac Surgery
NCT05361824Phase 4Completed
- Sponsor
- National Institute of Cardiovascular Diseases
- Start
- Jan 2021
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of ketorolac in postoperative pain (2 arms), sponsored by National Institute of Cardiovascular Diseases. Primary endpoint: Visual Analog Scale Pain Score at 24 hours. Started Jan 2021; status: completed.
02
Drugs
ketorolac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05361824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05361824.